Analysts think SNOA stock price could increase by 1722%
Jun 14, 2024, 6:29 AM
-0.27%
What does SNOA do
Sonoma Pharmaceuticals, Inc., headquartered in Boulder, Colorado, specializes in developing hypochlorous acid (HOCl) products for various medical and veterinary applications, including wound and scar care. Their product lineup includes Regenacyn Scar Gels, Pediacyn Skin Care, and MicrocynAH for animal health, with the company going public in 2007.
3 analysts think SNOA stock price will increase by 1722.43%. The current median analyst target is $3.31 compared to a current stock price of $0.18. The lowest analysts target is $3.28 and the highest analyst target is $3.41.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
